Application 208609
- Type
- NDA
- Sponsor
- AKORN INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EPHEDRINE SULFATE | EPHEDRINE SULFATE | SOLUTION;INTRAVENOUS | 50MG/ML (50MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N208609-001 | EPHEDRINE SULFATE | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2017-03-01 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N208609-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-01 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208609-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N208609-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N208609-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N208609-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N208609-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N208609-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N208609-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N208609-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N208609-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N208609-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N208609-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N208609-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N208609-001 | AP | 1 | ea99ee380514… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N208609-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N208609-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N208609-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N208609-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N208609-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N208609-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N208609-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N208609-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N208609-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N208609-001 | AP | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ephedrine sulfate | EPHEDRINE SULFATE | Medical Purchasing Solutions, LLC | 08f5ec19-7b53-681b-e063-6294a90acc86 | 2023-10-30 | Warnings, Adverse reactions | Ephedrine sulfate EPHEDRINE SULFATE |
| Ephedrine sulfate | EPHEDRINE SULFATE | Dr. Reddy's Laboratories, Inc. | 1d1c41c1-8f5f-ee76-c890-4f1f2a3b2e96 | 2023-08-01 | Warnings, Adverse reactions | Ephedrine sulfate EPHEDRINE SULFATE |
| EPHEDRINE SULFATE | EPHEDRINE SULFATE | Par Health USA, LLC | a247857e-ba7b-4a37-b132-4ba9b0d1c4d1 | 2023-05-31 | Warnings, Adverse reactions | EPHEDRINE SULFATE EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Medical Purchasing Solutions, LLC | d163ff39-d1a4-b61f-e053-2995a90ab6d5 | 2023-05-02 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Medical Purchasing Solutions, LLC | c8e8ec0e-988b-85a1-e053-2a95a90a2268 | 2023-04-25 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Xiromed, LLC | 8302176c-d443-97f1-1a49-12b9a204121a | 2023-04-11 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Civica, Inc. | 8f6c6588-77b6-40c7-a897-52e881854d7f | 2023-03-31 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Sagent Pharmaceuticals | 614e6649-a0e1-4428-855b-363abdb126d8 | 2023-03-03 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| ephedrine sulfate | EPHEDRINE SULFATE | Baxter Healthcare Corporation | 552c341b-4892-4dc7-8b9f-cb6be914b0d1 | 2023-01-20 | Warnings, Adverse reactions | ephedrine sulfate EPHEDRINE SULFATE |
| Emerphed | EPHEDRINE SULFATE | Nexus Pharamaceuticals Inc. | e1323592-dc57-4c9d-b84d-442648a7b114 | 2022-09-30 | Warnings, Adverse reactions | EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Fresenius Kabi USA, LLC | 5ecd9746-25c7-4bd4-9503-eb97e7db5aa5 | 2022-08-24 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| EPHEDRINE SULFATE | EPHEDRINE SULFATE | Par Health USA, LLC | 2c203482-8a04-40fc-93d2-74b30dec7742 | 2022-04-30 | Warnings, Adverse reactions | EPHEDRINE SULFATE EPHEDRINE SULFATE |
| Ephedrine sulfate | EPHEDRINE SULFATE | Lifestar Pharma LLC | 49fc67d1-3b30-456b-951c-ca7f703432ab | 2022-04-22 | Warnings, Adverse reactions | Ephedrine sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Gland Pharma Limited | 4a66e6c1-6d01-46fa-a2da-566fbf6e11a4 | 2022-03-04 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Akovaz | EPHEDRINE SULFATE | Exela Pharma Sciences, LLC | e92f3eda-33eb-4b34-9e8b-db8d32a5dbd9 | 2020-11-27 | Warnings, Adverse reactions | EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Sandoz Inc | c8af7bb5-41da-4f8c-8acd-f489892a0d72 | 2020-05-20 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 17478-415 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn | NDA | Current |
| 17478-415 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn | NDA | Current |
| 17478-415 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-415 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn | NDA | Current |
| 17478-415 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-415 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-415 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-517 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn | NDA | Current |
| 17478-517 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn | NDA | Current |
| 17478-517 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-517 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn | NDA | Current |
| 17478-517 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-517 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-517 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-955 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn | NDA | Current |
| 17478-955 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-955 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn, Inc. | NDA | Current |
| 17478-955 | Ephedrine Sulfate | Ephedrine Sulfate | Akorn | NDA | Current |